Dark Pharma · DP-027

SHE APPROVED THE INVOICE FOR £47,000. THE SAME DRUG COST £39 THE YEAR BEFORE. THE CLINICAL AUTHORITY SAID THERE WAS NO APPEAL.

In July 2017, a procurement officer processed an invoice for hydrocortisone tablets at an astonishing price of £47,000 per pack, up from £39 the previous year. Despite raising concerns about the price, the manager stated there was no appeal process once approval was granted.

Case Assets

The Case Debrief is free to view. Full Case Study, Teaching Notes, Slide Deck, Discussion Guide, and Assessment are available with a Premium subscription.

Brief the Board PREMIUM
🔒 Unlock
Learn the Case FREE — included
Study the Case PREMIUM
🔒 Unlock
Teach the Case PREMIUM
🔒 Unlock
Present the Case PREMIUM
🔒 Unlock
Run a Team Discussion PREMIUM
🔒 Unlock
Test Your Judgement PREMIUM
🔒 Unlock

Watch the Full Episode

The complete cinematic audio documentary — Dark Pharma

Unlock the Full Case Library

Get every Case Study, Slide Deck, Teaching Notes, Discussion Guide, and Assessment — across a growing library of business cases.

View Pricing →

Related Cases

Cases that share a governance or behavioural model with this one.